Skip to main content
Premium Trial:

Request an Annual Quote

C-Path Using Rosetta's Resolver in Predictive Safety Testing Consortium

NEW YORK (GenomeWeb News) – The Critical Path Institute will use Rosetta Biosoftware’s Resolver system, Rosetta said today.
 
C-Path will use the software for data management and analysis in its Predictive Safety Testing Consortium, which is a collection of pharmaceutical companies that work with C-Path to share information that may help improve drug safety.
 
C-Path is a publicly funded research and education institute in Tuscon, Ariz., and is a research arm of the US Food and Drug Administration’s Critical Path Initiative.
 
Financial terms of the deal were not released.

Filed under

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.